Cargando…
Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT
BACKGROUND: The aim of this study was to investigate the efficacy and safety of the novel complex drug, consisting of released-active form of antibodies to S-100 protein, tumor necrosis factor-α and histamine, (Kolofort) under outpatient conditions in patients with functional dyspepsia (FD), irritab...
Autores principales: | Ivashkin, Vladimir T., Poluektova, Elena A., Glazunov, Alexey B., Putilovskiy, Mikhail A., Epstein, Oleg I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938622/ https://www.ncbi.nlm.nih.gov/pubmed/31892312 http://dx.doi.org/10.1186/s12876-019-1143-5 |
Ejemplares similares
-
Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial
por: Pushkar, Dmitry, et al.
Publicado: (2018) -
Health Tract No. 309: Comfort
Publicado: (1868) -
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022) -
Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
por: Ivashkin, Vladimir, et al.
Publicado: (2023) -
Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)